Morgan Stanley »

Perspective Therapeutics shares owned by Morgan Stanley

Quarter-by-quarter ownership of Perspective Therapeutics (CATX) shares owned by Morgan Stanley from 13F filings

Historical chart of Morgan Stanley investment in Perspective Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Perspective Therapeutics held by Morgan Stanley consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Perspective Therapeutics by Morgan Stanley

Quarter filed Position value Share count Share price at filing
2024-06-30 $1.5M 152k 9.97

More positions owned by Morgan Stanley

Microsoft Corporation (MSFT)
Microsoft Corporation (MSFT)
Apple (AAPL)
Apple (AAPL)
NVIDIA Corporation (NVDA)
NVIDIA Corporation (NVDA)
Amazon (AMZN)
Amazon (AMZN)
Alphabet Cap Stk Cl A (GOOGL)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)

View all positions for Morgan Stanley

Top funds holding Perspective Therapeutics

Commodore Capital
Henderson Group
BlackRock
Avidity Partners Management
Vanguard Group
Deerfield Management Company
Nicholson Wealth Management Group
Octagon Capital Advisors
Marshall Wace
Geode Capital Management
Hills Bank And Trust Company
State Street Corporation
Ghost Tree Capital
Paradigm Biocapital Advisors
Sphera Funds Management

View all funds holding Perspective Therapeutics